JP2010513250A5 - - Google Patents

Download PDF

Info

Publication number
JP2010513250A5
JP2010513250A5 JP2009540783A JP2009540783A JP2010513250A5 JP 2010513250 A5 JP2010513250 A5 JP 2010513250A5 JP 2009540783 A JP2009540783 A JP 2009540783A JP 2009540783 A JP2009540783 A JP 2009540783A JP 2010513250 A5 JP2010513250 A5 JP 2010513250A5
Authority
JP
Japan
Prior art keywords
composition according
composition
diabetes
hyperglycemia
glutamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009540783A
Other languages
English (en)
Japanese (ja)
Other versions
JP5580050B2 (ja
JP2010513250A (ja
Filing date
Publication date
Priority claimed from EP06026072A external-priority patent/EP1932542A1/en
Application filed filed Critical
Priority claimed from PCT/EP2007/063970 external-priority patent/WO2008071790A2/en
Publication of JP2010513250A publication Critical patent/JP2010513250A/ja
Publication of JP2010513250A5 publication Critical patent/JP2010513250A5/ja
Application granted granted Critical
Publication of JP5580050B2 publication Critical patent/JP5580050B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009540783A 2006-12-15 2007-12-14 組成物およびその使用 Expired - Fee Related JP5580050B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US87020006P 2006-12-15 2006-12-15
EP06026072A EP1932542A1 (en) 2006-12-15 2006-12-15 Antioxidant composition and its use in diabetes
EP06026072.6 2006-12-15
US60/870,200 2006-12-15
PCT/EP2007/063970 WO2008071790A2 (en) 2006-12-15 2007-12-14 Novel compositions and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014036114A Division JP2014132017A (ja) 2006-12-15 2014-02-27 組成物およびその使用

Publications (3)

Publication Number Publication Date
JP2010513250A JP2010513250A (ja) 2010-04-30
JP2010513250A5 true JP2010513250A5 (cg-RX-API-DMAC7.html) 2011-01-13
JP5580050B2 JP5580050B2 (ja) 2014-08-27

Family

ID=39309971

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009540783A Expired - Fee Related JP5580050B2 (ja) 2006-12-15 2007-12-14 組成物およびその使用
JP2014036114A Pending JP2014132017A (ja) 2006-12-15 2014-02-27 組成物およびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014036114A Pending JP2014132017A (ja) 2006-12-15 2014-02-27 組成物およびその使用

Country Status (7)

Country Link
EP (1) EP2117596B1 (cg-RX-API-DMAC7.html)
JP (2) JP5580050B2 (cg-RX-API-DMAC7.html)
KR (1) KR101487852B1 (cg-RX-API-DMAC7.html)
AU (1) AU2007331447B2 (cg-RX-API-DMAC7.html)
CA (1) CA2673054C (cg-RX-API-DMAC7.html)
EA (1) EA016926B1 (cg-RX-API-DMAC7.html)
WO (1) WO2008071790A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190062609A (ko) * 2009-01-12 2019-06-05 바이오키어 인코포레이티드 당뇨병 치료 조성물 및 치료방법
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
MX2011012764A (es) 2009-06-26 2012-01-20 Novo Nordisk As Preparacion que comprende insulina, nicotinamida y un aminoacido.
US9301938B2 (en) 2009-09-23 2016-04-05 Biokier, Inc. Composition and method for treatment of diabetes
WO2012095509A1 (en) * 2011-01-14 2012-07-19 Tima Foundation Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases
EP2594141A1 (en) * 2011-11-15 2013-05-22 TIMA Foundation Composition for protection against cell-damaging effects
WO2013072441A1 (en) * 2011-11-15 2013-05-23 Tima Foundation Composition for protection against cell-damaging effects
CN103099211A (zh) * 2012-12-21 2013-05-15 洪万雄 一种融合辅酶q10的广谱性一氧化氮保健品
MX2017001737A (es) * 2014-08-08 2017-04-27 Nestec Sa Vitamina b2 y sus usos.

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0229047B2 (ja) * 1982-05-29 1990-06-27 Snow Brand Milk Prod Co Ltd Tonyobyochiryozai
JPS60126125A (ja) * 1983-12-09 1985-07-05 松下電器産業株式会社 ジユ−サ
JPH0610132B2 (ja) * 1985-11-27 1994-02-09 千寿製薬株式会社 糖尿病性白内障治療薬
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
JP3581157B2 (ja) * 1992-08-19 2004-10-27 株式会社ミツカングループ本社 低耐糖能者用食品
US20020155163A1 (en) * 1999-12-27 2002-10-24 Samuel D. Benjamin Integrated multi-vitamin and mineral combination
US20040137036A1 (en) * 2001-05-09 2004-07-15 Yoshitane Kojima Zinc-containing foods
ITTO20010580A1 (it) * 2001-06-15 2002-12-15 Professional Dietetics Srl Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
JP2003116486A (ja) * 2001-08-09 2003-04-22 Meiji Milk Prod Co Ltd 食後の血糖上昇抑制作用を有する食品組成物
CN1694695A (zh) * 2002-11-07 2005-11-09 帝斯曼知识产权资产管理有限公司 包含表没食子儿茶素没食子酸酯的新颖的营养药物性组合物
AU2003289196A1 (en) * 2002-12-06 2004-06-30 Sunstar Inc. Composition containing green and yellow vegetables and light-colored vegetables
SI1720610T1 (sl) * 2004-02-17 2011-02-28 Matuschka Greiffenclau Markus Graf V Sestavek za vplivanje na presnavljanje alkohola
WO2005110394A1 (ja) * 2004-05-19 2005-11-24 Ajinomoto Co., Inc. 糖尿病治療薬
DK1909600T3 (da) * 2005-07-29 2012-07-30 Tima Foundation Sammensætning til moderering af alkoholmetabolisme og til at reducere risikoen for alkoholforårsagede sygdomme
WO2007016949A1 (en) * 2005-07-29 2007-02-15 Matuschka-Greiffenclau Markus Composition for reducing the risc of alcohol induced neuropathy

Similar Documents

Publication Publication Date Title
JP2010513250A5 (cg-RX-API-DMAC7.html)
Nooh et al. Intranasal atomized dexmedetomidine for sedation during third molar extraction
ES2912306T3 (es) Tetratiomolibdato de bis-colina para el tratamiento de enfermedad de Wilson
JP2016510031A5 (ja) モノカルボキシラート輸送体を伴うγ−ヒドロキシブチラートの投与
ES2585884T3 (es) Regímenes terapéuticos
JP2018526407A5 (cg-RX-API-DMAC7.html)
JP2014515408A5 (cg-RX-API-DMAC7.html)
JP2017510607A5 (cg-RX-API-DMAC7.html)
JP7123205B2 (ja) 経口用医薬組成物
AU2020334128B2 (en) Compositions comprising a metal and L-serine, and uses thereof
WO2004017973A1 (ja) 統合失調症治療剤
Gallottini et al. General anesthesia and dental sedation in patients with special needs: why, when and how. A clinical guide for dental practitioners
JP2011116775A (ja) 局所脳血流低下に伴う神経系障害の予防または治療のための医薬組成物
Gurung et al. Safety profile and patient satisfaction of the routine use of propofol in gastrointestinal endoscopy
EP4218750A1 (en) The use of melanin in therapy of subjects with trisomy 21
WO2025162430A1 (zh) 一种药物联用及其在预防或治疗神经退行性疾病中的用途
JP6738797B2 (ja) レット症候群治療薬
RU2641163C1 (ru) Способ лечения устойчивых пароксизмальных состояний и генерализованных миоклоний у пациентов с последствиями тяжелого поражения головного мозга
Koganti et al. Medical conditions, medications and gerodontology
CN103301115A (zh) 一种治疗癫痫的药物组合物
JP2022500420A (ja) 睡眠又は睡眠後パフォーマンスの改善
WO2007073134A1 (es) Composiciones farmaceuticas que comprenden sustancias inhibidoras de las lipasas intestinales combinadas con un complejo o-coordinado de dinicotinato de cromo para su uso en el tratamiento y control de la obesidad o sobrepeso
Frank et al. Udicolic 300 MG Tablet 10
Frank Udoript 300 Tablet 10
Frank et al. Ursoapp 300 MG Tablet 10